Sofie

IN THE PRESS

Policy

SOFIE to Commercially Supply FDA-Approved PYLARIFY® (piflufolastat F 18) Injection

May 28, 2021

·

6 min read

BioCapital

SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics

March 30, 2021

·

2 min read

Business

SOFIE Signs Commercial Supply Agreement with Lantheus Holdings, Inc. to Manufacture PyL™ (18F-DCFPYL), a PSMA-targeted Prostate Cancer Imaging Agent

November 12, 2020

·

3 min read

Business

Sofie Biosciences Enters Strategic Collaboration For The Production And Distribution Of FAPI Precursors

October 10, 2019

·

3 min read

Business

SOFIE Breaks Ground On 30,000 Sq Ft Theranostic Center Of Excellence

June 24, 2019

·

4 min read

Biotech Beach

SOFIE And University Clinic Heidelberg Sign License Agreement For Theranostics That Target Cancer Associated Fibroblasts

June 21, 2019

·

4 min read

Deals

Sofie Expands Its Network By Acquiring Cyclotope Radiopharmacy From Houston Cyclotron Partners

June 17, 2019

·

3 min read

Biotech Beach

SOFIE is Awarded $5M from Three Major SBIR Grants

October 5, 2018

·

2 min read

Deals

Acquisition Of Zevacor Pharma Complete, Rebranding As Sofie

September 28, 2017

·

6 min read

Biotech Bay

Exclusive Interview: Dr. Sofie Qiao, CEO Of Vivace

July 28, 2017

·

1 min read

JOBS